ProfileGDS4718 / 212301_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 86% 91% 86% 87% 88% 87% 88% 85% 86% 87% 86% 85% 83% 87% 87% 88% 83% 84% 74% 86% 87% 86% 87% 85% 86% 89% 86% 84% 85% 88% 91% 85% 86% 84% 83% 85% 86% 86% 92% 88% 78% 83% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4913985
GSM549102patient 115, normal, homogenized [OPG study]8.4819986
GSM549104patient 119, normal, homogenized [OPG study]9.4169391
GSM549108patient 138, normal, homogenized [OPG study]8.4915386
GSM549119patient 077, normal, homogenized [OPG study]8.6601787
GSM549133patient 032, cancer, homogenized [OPG study]8.9504388
GSM549139patient 042, cancer, homogenized [OPG study]8.701587
GSM549099patient 107, normal, homogenized [OPG study]8.7529588
GSM549109patient 139, normal, homogenized [OPG study]8.3718285
GSM549110patient 046, normal, homogenized [OPG study]8.6558186
GSM549114patient 063, normal, homogenized [OPG study]8.8098787
GSM549122patient 082, normal, homogenized [OPG study]8.5329686
GSM549134patient 033, cancer, homogenized [OPG study]8.5414985
GSM549136patient 036, cancer, homogenized [OPG study]8.328283
GSM549140patient 044, cancer, homogenized [OPG study]8.855687
GSM549111patient 047, normal, homogenized [OPG study]8.8063887
GSM549113patient 057, normal, homogenized [OPG study]9.064688
GSM549132patient 031, cancer, homogenized [OPG study]8.2651883
GSM549137patient 038, cancer, homogenized [OPG study]8.4075584
GSM549142patient 047, cancer, homogenized [OPG study]7.1702974
GSM549100patient 110, normal, homogenized [OPG study]8.5616586
GSM549107patient 135, normal, homogenized [OPG study]8.839587
GSM549115patient 068, normal, homogenized [OPG study]8.8310786
GSM549116patient 072, normal, homogenized [OPG study]8.7968487
GSM549120patient 078, normal, homogenized [OPG study]8.4980585
GSM549131patient 030, cancer, homogenized [OPG study]8.6958986
GSM549118patient 074, normal, homogenized [OPG study]9.0228189
GSM549129patient 027, cancer, homogenized [OPG study]8.5457586
GSM549123patient 088, normal, homogenized [OPG study]8.4086584
GSM549124patient 006, cancer, homogenized [OPG study]8.4002985
GSM549126patient 015, cancer, homogenized [OPG study]8.7748388
GSM549128patient 025, cancer, homogenized [OPG study]9.3894591
GSM549103patient 117, normal, homogenized [OPG study]8.3537485
GSM549117patient 073, normal, homogenized [OPG study]8.7096586
GSM549138patient 041, cancer, homogenized [OPG study]8.3290284
GSM549141patient 045, cancer, homogenized [OPG study]8.3466583
GSM549130patient 028, cancer, homogenized [OPG study]8.4210385
GSM549101patient 111, normal, homogenized [OPG study]8.5927486
GSM549105patient 128, normal, homogenized [OPG study]8.6199486
GSM549106patient 134, normal, homogenized [OPG study]9.7460292
GSM549112patient 048, normal, homogenized [OPG study]8.8644188
GSM549125patient 011, cancer, homogenized [OPG study]7.5479978
GSM549127patient 024, cancer, homogenized [OPG study]8.2074183
GSM549135patient 035, cancer, homogenized [OPG study]9.0480889